IGEN rests dase against Roche.(Brief Article)

IGEN International, Inc. (Gaithersburg, MD; 301-869-9800) announced that it has concluded its presentation to the jury in its multi-count lawsuit against Roche Diagnostics, a division of F. Hoffmann-La Roche. The trial began on October 23. Over the past several weeks, the jury heard testimony from IGEN's senior executives, four expert witnesses, and Roche senior executives supporting IGEN's allegations in the case. Roche is set to begin its case on November 27 and the case is scheduled to be completed by the end of the year.

Prior to the start of trial, the court had already granted summary judgment in IGEN's favor on three of IGEN's breach of contract claims. The …